Effect of Spironolactone on 30-Day Death and Heart Failure Rehospitalization (from the COACH Study)

Overview of attention for article published in American Journal of Cardiology, June 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 7,146 followers.

Effect of Spironolactone on 30-Day Death and Heart Failure Rehospitalization (from the COACH Study) http://t.co/D0uBuRCRO2

Effect of Spironolactone on 30-Day Death and Heart Failure Rehospitalization (from the COACH Study) http://t.co/ZHGdGHrh56

Effect of Spironolactone on 30-Day Death and Heart Failure Rehospitalization (from the COACH Study) http://t.co/ZgDekVkYpq

Espironolactona administrada durante el ingreso de una ICA: menos mortalidad a los 30 días y reingresos por ICA. http://t.co/5rJAhRzAW5

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.